Key result
Multimodal atrial substrate characterization aids prediction of AF onset, progression, and rhythm-control outcomes.
Why the study?
Atrial fibrillation reflects an underlying atrial disease process that conventional temporal classification incompletely captures, prompting evaluation of established and emerging atrial substrate markers for risk stratification.
Does multimodal atrial substrate characterization improve prediction of atrial fibrillation onset, progression, thromboembolic complications, and outcomes after rhythm-control therapy in patients with or at risk for atrial fibrillation?
Does multimodal atrial substrate characterization improve prediction of atrial fibrillation onset, progression, thromboembolic complications, and outcomes after rhythm-control therapy in patients with or at risk for atrial fibrillation?
Multimodal characterization of electrical, structural, mechanical, and hemodynamic atrial substrate remodelling holds promise for improving atrial fibrillation risk stratification and guiding rhythm-control therapy, though standardized methods and prospective validation are still needed.
Answers are grounded in this paper and cite their sources.
May enhance AF risk stratification; leaves open standardization of thresholds and prospective validation before clinical use.
Purpose of review Atrial fibrillation is increasingly recognized as a manifestation of an underlying atrial disease process that is incompletely captured by conventional temporal classification. This review examines established and emerging markers of atrial substrate and their potential role in atrial fibrillation risk stratification. Recent findings Electrocardiographic indices, left atrial volumetric and strain measures, computed tomography-derived left atrial wall characteristics, late gadolinium enhancement and flow assessment by cardiac magnetic resonance, high-density electroanatomic mapping, circulating biomarkers and genetic profiling provide complementary measures of electrical, structural, mechanical and hemodynamic remodelling. Recent studies have refined noninvasive identification of low-voltage substrate and risk stratification of atrial fibrillation progression and complications, evaluated substrate-guided ablation strategies, and expanded understanding of the prognostic significance of emerging substrate markers. Summary Multimodal atrial substrate characterization may improve prediction of atrial fibrillation onset and progression, thromboembolic complications and outcomes after rhythm-control therapy. Clinical translation requires standardized acquisition and analytical methods, reproducible thresholds, prospective validation of integrated risk models, and prospective trials demonstrating improved outcomes with substrate-guided management.
No takes yet. Share an insight, caveat, or question.
Virk et al. (2026) conducted a review in Atrial fibrillation. Multimodal atrial substrate characterization was evaluated on Atrial fibrillation onset and progression, thromboembolic complications, and outcomes after rhythm-control therapy. Multimodal atrial substrate characterization may improve prediction of atrial fibrillation onset, progression, thromboembolic complications, and rhythm-control outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: